We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Diurnal Group Plc | LSE:DNL | London | Ordinary Share | GB00BDB6Q760 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.30 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
17/3/2021 10:24 | I don't see 62p | aimmafia | |
17/3/2021 10:00 | Seems to be holding up this morning, if not I can see 62p being the retrace and then a bounce. | l0ngterm | |
17/3/2021 06:42 | The SAP seems like a quick waiver to get product in ahead of regulations approval. As long as they can seel Sprinkle in through the SAP then approval is a given. Great update and EU confirmation of Chronocto come what is not to like. GLA | tburns | |
17/3/2021 06:35 | af Exactly my thoughts it will be the golden goose for DNL over the pond and then Canada also using the Special Access Program. | simon_64 | |
17/3/2021 06:14 | said Sean Brynjelsen, CEO of Eton Pharmaceuticals. "With these recent events, we believe we have a clear pathway to achieve of our goal of profitability by the end of 2021 and we expect to report more than $25 million of revenue in 2021."Those projections of more than USD 25m in 2021, include other medical products apart from Alkindi Sprinkle, but you do get the impression that Alkindi is the main focus within their medical portfolio for this year (2021). | affc21 | |
17/3/2021 02:51 | 9 trading days to go peeps, like opening an advent calendar when i was a kid. Sooooo exciting. | simon_64 | |
17/3/2021 02:28 | Due to the strong initial reception to ALKINDI SPRINKLE in the United States and inbound interest from Canadian patients and physicians, Eton acquired the Canadian rights to ALKINDI SPRINKLE in January 2021. Eton is exploring the possibility of immediately supplying the product to patients through Canada’s Special Access Program while it works on compiling the product’s regulatory application to seek formal approval from Health Canada." | simon_64 | |
17/3/2021 02:18 | I think that is very positive as l0ngterm says this is about the future not the present and the market always looks ahead. | simon_64 | |
17/3/2021 01:00 | Positive considering the time frame and environment, that and once sales booked then it is all recurring revenue. | l0ngterm | |
16/3/2021 21:43 | Eton launched ALKINDI SPRINKLE in late 2020 and promotional activities have accelerated in 2021. The company's pediatric endocrinology focused sales force has now reached a large number of the company's initial targets. In addition to virtual meetings, sales reps are beginning to hold in-person meetings with prescribers as COVID restrictions have started to ease. The company expects the rate of in-person meetings to increase in the coming months, which is expected to drive even greater adoption of ALKINDI SPRINKLE. New patient starts have grown every month since launch, and the company expects the growth to continue. | s34icknote | |
16/3/2021 21:39 | ETON sales not really got going yet.. unsurprising really considering it only launched in Nov so less than a two month period covered in the ETON financials and with so many restrictions still in place its a false picture atm | trotterstrading | |
16/3/2021 21:27 | https://ir.etonpharm | affc21 | |
16/3/2021 21:17 | Link please | aimmafia | |
16/3/2021 20:26 | Update is on Eton's website now | l0ngterm | |
16/3/2021 16:07 | I will be happy to consolidate here today at 67/68 - Still flat after all those sells, spells good news to me. | aimmafia | |
16/3/2021 15:35 | Afternoon all. Not surprised at the sell off been a decent rise some profit takers 10% crowd and some top slicing going on from 30's. I am certain and there is a large background buyer still, expect to see another RNS over the next couple of sessions. | simon_64 | |
16/3/2021 12:14 | Seems 69 was the next stop, resistance. Not often I get that right | l0ngterm | |
16/3/2021 11:09 | Mms gobbling up those shares - I could sell 50,000 earlier for 67p no problem | aimmafia | |
16/3/2021 10:35 | RG selling this to buy RENE it seems. I've got both so no worries. | small crow | |
16/3/2021 10:19 | Tax year is ending so people will be selling and buying as well for those reasons. | aimmafia | |
16/3/2021 10:09 | I think selling now is crazy but everyone has different reasons so cannot speak for them.There are so many things going for this at present so will hold for my price target of 120 pence for starters and who knows it may be higher after Chroncort | glasswala | |
16/3/2021 09:15 | Tburns. Yesterday's reported closing price was skewed (-2%) at 1635.It's opened up this morning where it closed, recovering the 'lost' 2%.In reality opened flat, if you get my drift :) | mufprat | |
16/3/2021 09:14 | Maybe RG had finally run out :-) | tburns | |
16/3/2021 09:03 | Yep bidding almost mid and can’t buy any size at all | shrewdmole | |
16/3/2021 09:00 | Bid and ask are way behind where we are | aimmafia |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions